Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

PROSHARES TRUST (ZBIO) Research & Development: 2023-2024

Historic Research & Development for Zenas BioPharma (ZBIO) over the last 2 years, with Dec 2024 value amounting to $139.1 million.

  • Zenas BioPharma's Research & Development rose 2.60% to $34.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $161.5 million, marking a year-over-year increase of 46.29%. This contributed to the annual value of $139.1 million for FY2024, which is 131.77% up from last year.
  • According to the latest figures from FY2024, Zenas BioPharma's Research & Development is $139.1 million, which was up 131.77% from $60.0 million recorded in FY2023.
  • In the past 5 years, Zenas BioPharma's Research & Development ranged from a high of $139.1 million in FY2024 and a low of $60.0 million during FY2023.
  • Its 2-year average for Research & Development is $99.6 million, with a median of $99.6 million in 2023.
  • Data for Zenas BioPharma's Research & Development shows a peak YoY soared of 131.77% (in 2024) over the last 5 years.
  • Over the past 2 years, Zenas BioPharma's Research & Development (Yearly) stood at $60.0 million in 2023, then soared by 131.77% to $139.1 million in 2024.